Please login to the form below

Movymia

This page shows the latest Movymia news and features for those working in and with pharma, biotech and healthcare.

CHMP recommends Merck & Co's Lantus biosimilar

Hungarian pharmaceutical firm Gedeon Richter and Germany's Stada Arzneimittel received recommendations for Terrosa and Movymia respectively, for the treatment of postmenopausal women and men at increased risk of fracture.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Medical Writer: Salary TBC

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Director, Medical Education: Salary TBC

Senior Medical Writer: Salary TBC

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Director – Healthcare Marketing – Berks: Salary TBC

Associate Director: £75, 000-90, 000

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Global Business Development Director – Health Education: excellent commission

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Account Director development role to Business Director, H...: Excellent package

Account Manager / Account Director: Competative

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Account Director – Health Policy – Global Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...